Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments
US7491719B2 · kind B2 · utility
6Cited by
26References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2006 |
| Grant date | Feb 17, 2009 |
| Priority date | — |
| Expiry date | Oct 4, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Enantiomerically pure compounds of general formula 1wherein the groups R1, R2, R3, R4, and X− may have the meanings given in the claims and in the specification, processes for preparing them and the use thereof as pharmaceutical compositions, particularly as pharmaceutical compositions for the treatment of respiratory complaints.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.